IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Public ClinicalTrials.gov record NCT00977756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMPAACT P1058A: Intensive Pharmacokinetic Studies of New Classes of Antiretroviral Drug Combinations in Children, Adolescents and Young Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will examine drug and body interactions in children receiving anti-HIV treatment regimens using new medications. Drug regimens to be examined will feature the medications raltegravir (RAL), maraviroc (MVC), and etravirine (ETV). These drugs will not be provided through the study.
Study identification
- NCT ID
- NCT00977756
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Interventions
- Raltegravir (RAL) Drug
- Atazanavir (ATV) Drug
- Ritonavir (RTV) Drug
- Tenofovir (TDF) Drug
- Etravirine (ETV) Drug
- Darunavir (DRV) Drug
- Maraviroc (MVC) Drug
- Lopinavir/ritonavir (LPV/r) Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2002 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Aug 7, 2015
2002 – 2014
United States locations
- U.S. sites
- 33
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. of Alabama Birmingham NICHD CRS (5096) | Birmingham | Alabama | 35294 | — |
| Miller Children's Hospital Long Beach, CA NICHD CRS (5093) | Long Beach | California | 90806 | — |
| Usc La Nichd Crs (5048) | Los Angeles | California | 90033 | — |
| UCSD Mother, Child & Adolescent HIV Program(4601) | San Diego | California | 92103 | — |
| Univ. of California San Francisco NICHD CRS (5091) | San Francisco | California | 94117 | — |
| Harbor (UCLA) Medical Center NICHD CRS (5045) | Torrance | California | 90509 | — |
| Harbor Univeristy of California, Los Angeles (UCLA) Medical Center (603) | Torrance | California | 90509 | — |
| Childrens Hospital (U. Colorado, Denver) NICHD CRS (5052) | Denver | Colorado | 80218-1088 | — |
| Children's National Medical Center (5015) | Washington D.C. | District of Columbia | 20010 | — |
| South Florida CDC Ft Lauderdale NICHD CRS (5055) | Fort Lauderdale | Florida | 33316 | — |
| University of Miami Pediatric Perinatal HIV/AIDS CRS (4201) | Miami | Florida | 33136 | — |
| University of South Florida Tampa (5018) | Tampa | Florida | 33620 | — |
| Rush University Cook County (5083) | Chicago | Illinois | 60612 | — |
| Chicago Children's CRS (4001) | Chicago | Illinois | 60614 | — |
| University of Maryland NICHD CRS (5094) | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University NICHD CRS (5092) | Baltimore | Maryland | 21287 | — |
| Children's Hospital of Boston NICHD CRS (5009) | Boston | Massachusetts | 02115 | — |
| Boston Medical Center Ped. HIV Program NICHD CRS (5011) | Boston | Massachusetts | 02118 | — |
| WNE Maternal Pediatric Adolescent AIDS CRS (7301) | Worcester | Massachusetts | 01605 | — |
| New Jersey Medical School (NJ) (2802) | Newark | New Jersey | 07103 | — |
| New York University NY (5012) | New York | New York | 10016 | — |
| Metropolitan Hospital (5003) | New York | New York | 10029 | — |
| Columbia IMPAACT CRS (4101) | New York | New York | 10032 | — |
| SUNY Stony Brook NICHD CRS (5040) | Stony Brook | New York | 11794 | — |
| Bronx-Lebanon Hospital (6901) | The Bronx | New York | 10457 | — |
| Jacobi Medical Center Bronx (5013) | The Bronx | New York | 10461 | — |
| Duke University Medical Center (DUMC) (4701) | Durham | North Carolina | 27710 | — |
| The Children's Hosp. of Philadelphia IMPAACT CRS (6701) | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude/UTHSC CRS (6501) | Memphis | Tennessee | 38105 | — |
| Texas Children's Hosp. CRS (3801) | Houston | Texas | 77030 | — |
| Harborview Medical Center NICHD CRS (5027) | Seattle | Washington | 98105 | — |
| Univ of Washington Children's Hospital Seattle (5017) | Seattle | Washington | 98105 | — |
| University of Washington NICHD CRS (5029) | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00977756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00977756 live on ClinicalTrials.gov.